C

Cedar Crosse Research Center | Chicago, IL

Research site

(Unclaimed)

Location

800 S.Wells, Suite M15, Chicago, Illinois, United States of America

Site insights

Top conditions

Top treatments

Dapagliflozin

Empagliflozin

BMS-512148

PS433540

Ramipril

ABP-450

Metformin

Firibastat

Thiazolidinedione

Polypill

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 42 total trials

Status recently updated

A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study of Elismetrep (K-304) in the Treatment of Migraine

This is a double-blind, randomized, multicenter, outpatient evaluation of the safety and efficacy of elismetrep as compared to placebo in the treatme...

Not yet enrolling

Enrolling

Acute Migraine

Drug: Placebo

Drug: Elismetrep (K-304) Dose level 3

A Pivotal Study to Evaluate the Effectiveness of Isometric Handgrip Therapy in Elevated Blood Pressure and Hypertensive Subjects

The study will be a multi-center, randomized clinical trial to evaluate the safety and efficacy of using the Zona Plus handgrip therapy device compar...

Not yet enrolling

Hypertension

Elevated Blood Pressure

Device: Zona Plus Device

Other: Relaxing Music App

A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)

This study is open to adults who are at least 18 years old and have a body mass index (BMI)bof 27 kg/m2 or more. People can take part if they have ca...

Active, not recruiting

Obesity

Drug: Placebo

Drug: survodutide

Study of BMF-219 in Healthy Adult Subjects and in Adult Subjects With Type 2 Diabetes Mellitus (T2D)

A Phase 1/ 2 Randomized, Double-Blind, Placebo-Controlled Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokine...

Active, not recruiting

Type 2 Diabetes Mellitus

Drug: BMF-219

To Evaluate the Safety and Efficacy of MANP in Subjects With Difficult to Control/ Resistant Hypertension (BOLD-HTN)

This is a Phase 2 dose-titration study designed to evaluate the safety and efficacy of MANP subcutaneous injection compared to placebo in reducing ba...

Enrolling

Difficult to Control Hypertension

Drug: MANP

Other: Placebo Matched control